Evidence map›Paper›PMID 40723913›Full record

ArticleBiomolecules2025

Bilirubin Metabolism and Thyroid Cancer: Insights from ALBI and PALBI Indices.

Jong Won Shin, Jae Woong Sull, Nguyen Thien Minh, Sun Ha Jee

Abstract read
In one paragraph

Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jong Won ShinDepartment of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Ulsan, Seoul 05505, Republic of Korea.ORCID 0009-0003-8587-1445
Jae Woong SullDepartment of Biomedical Laboratory Science, College of Health Sciences, Eulji University, Seongnam 13135, Republic of Korea.ORCID 0000-0002-5178-0065
Nguyen Thien MinhDepartment of Epidemiology and Health Promotion, Institute for Health Promotion, School of Public Health, Yonsei University, Seoul 03772, Republic of Korea.ORCID 0009-0003-1090-6228
Sun Ha JeeDepartment of Epidemiology and Health Promotion, Institute for Health Promotion, School of Public Health, Yonsei University, Seoul 03772, Republic of Korea.ORCID 0000-0001-9519-3068

Funding

This study was supported by a MEF Fellowship conducted as part of the "Education and Research Capacity Building Project at University of Medicine and Pharmacy at Ho Chi Minh City," implemented by the Korea International Cooperation Agency (KOICA) in 2023 No. 2021-00020-3This study was supported by research funding from Basgen Bio for the years 2021-2026. none
6 · The paper itself

Abstract

backgroundThis study evaluated the association between bilirubin subtypes (total, indirect, and direct bilirubin) and thyroid cancer risk, with a particular focus on stratified analyses using the ALBI (Albumin-Bilirubin) and PALBI (Platelet-Albumin-Bilirubin) indices by sex, smoking and drinking status, and age under 50 years.

methodsData were obtained from 133,596 participants in the Korean Cancer Prevention Study-II (KCPS-II) cohort. During a mean follow-up period of 13.55 years, 2314 cases of thyroid cancer (ICD-10: C73) were identified. Serum bilirubin levels and ALBI and PALBI indices were analyzed using Cox proportional hazards regression models stratified by age, sex, smoking, and alcohol consumption status to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).

resultsIn women, indirect bilirubin showed the strongest inverse association with thyroid cancer risk. ALBI and PALBI indices based on indirect bilirubin also demonstrated significant associations. A 1 standard deviation (SD) increase in indirect bilirubin was associated with a decreased risk of thyroid cancer (HR: 0.92, 95% CI: 0.84-0.99), and the ALBI index similarly showed an inverse association (HR: 0.92, 95% CI: 0.87-0.99). In contrast, the PALBI index was positively associated with thyroid cancer risk (HR: 1.11, 95% CI: 1.03-1.20). Among women who had never smoked, significant associations were observed for indirect bilirubin (HR: 0.91, 95% CI: 0.83-1.00), ALBI (HR: 0.93, 95% CI: 0.86-1.00), and PALBI (HR: 1.14, 95% CI: 1.05-1.23). In analyses stratified by alcohol consumption, the PALBI index was associated with increased thyroid cancer risk in non-drinkers, former drinkers, and ever drinkers, with respective risk increases of 15%, 18%, and 9%.

conclusionsIn women, indirect bilirubin was significantly and inversely associated with thyroid cancer risk, and the ALBI and PALBI indices incorporating indirect bilirubin showed consistent results. These findings suggest that indirect bilirubin may play a critical role in the metabolic pathways underlying thyroid cancer in women.

Indexed as

BilirubinThyroid NeoplasmsAdultFemaleHumansMaleMiddle AgedProportional Hazards ModelsRepublic of KoreaRisk FactorsBilirubinalbuminantioxidantsbilirubinoxidative stressthyroid neoplasms

Identifiers

PMID40723913
PMCPMC12293926

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.